MARKET

TTNP

TTNP

Titan Pharmaceut
NASDAQ
7.32
+0.22
+3.09%
After Hours: 7.48 +0.16 +2.19% 09:30 04/19 EDT
OPEN
7.32
PREV CLOSE
7.10
HIGH
7.32
LOW
7.32
VOLUME
2.98K
TURNOVER
0
52 WEEK HIGH
16.90
52 WEEK LOW
5.00
MARKET CAP
6.69M
P/E (TTM)
-0.9884
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 20h ago
Weekly Report: what happened at TTNP last week (0408-0412)?
Weekly Report · 5d ago
Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Agenus Inc. (NASDAQ:AGEN) fell sharply during Monday's session. Auddia Inc. Shares jumped 231.7% to $4.72. The company announced a 1-for-20 reverse stock split of common stock.
Benzinga · 04/08 17:10
Galectin Therapeutics, Titan Pharmaceuticals, Outset Medical among healthcare movers
Galectin Therapeutics, Titan Pharmaceuticals, Outset Medical among healthcare movers. S&P 500 Health Care Sector -0.3% to 1665.92. Pharmaceuticals and Biotechnology & Life Science contributes 58% to the index.
Seeking Alpha · 04/08 14:00
Weekly Report: what happened at TTNP last week (0401-0405)?
Weekly Report · 04/08 10:54
THE SIRE GROUP LTD. - AS OF APRIL 2, FOUR OF TITAN PHARMACEUTICALS INC BOARD’S SEVEN DIRECTORS HAD BEEN NOMINATED BY REPORTING PERSONS
Reuters · 04/05 20:41
THE SIRE GROUP LTD - EXPECT TO PROPOSE TO TITAN PHARMACEUTICALS INC A BUSINESS COMBINATION WITH KE SDN. BHD
Reuters · 04/05 20:41
Titan Pharmaceuticals Overhauls Leadership, Settles with Ex-Directors
TipRanks · 04/03 21:23
More
About TTNP
Titan Pharmaceuticals, Inc. is a pharmaceutical company. The Company is focused on developing therapeutics utilizing the proprietary long-term drug delivery platform, ProNeura, for the treatment of select chronic diseases. ProNeura offers continuous drug delivery and consists of a small, semi-rigid, flexible implant made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The resulting product is a solid matrix implant that is placed subdermally, normally in the inside part of the upper arm, in a brief procedure using a local anesthetic and is removed in a similar manner at the end of the treatment period. Its product pipeline includes Kappa Opioid Receptor Agonist (TP-2021) Implant, which is used for the treatment of moderate-to-severe chronic pruritus. Its product development programs are in non-clinical stages of development.

Webull offers Titan Pharmaceuticals Inc stock information, including NASDAQ: TTNP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TTNP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TTNP stock methods without spending real money on the virtual paper trading platform.